Clik here to view.
Astute Medical raises $2 million
Astute Medical raised $2 million in a new round of debt financing, according to an SEC filing posted today. San Diego-based Astute Medical develops and produces the NephroCheck, a device designed to...
View ArticleClik here to view.
Apama Medical raises $13m
Novel catheter ablation tech developer Apama Medical raised $13.2 million in a new round of equity financing, according to an SEC filing posted today. Apama Medical is developing novel ablation...
View ArticleClik here to view.
Nanoparticle “barcodes” help track cancer drug efficacy
Researchers from Technion Institute of Technology in Israel reported on a method of tagging cancer drugs with “barcodes” to monitor tumor growth. The team detailed their methods in a study published in...
View ArticleClik here to view.
Appeals court upholds $15m Medtronic loss to bone cement acquisition Pabban...
Medtronic (NYSE:MDT) is still on the hook to pay $15.4 million to bone cement maker Pabban Development for breaking the terms their 2008 acquisition deal, a federal appeals court ruled yesterday....
View ArticleClik here to view.
Subject participation in clinical trials is paramount
Obtaining useful and meaningful data is one of the goals of any clinical trial. However, in order to attain the necessary data, subject participation in clinical trials is paramount as subjects are the...
View ArticleClik here to view.
Alere agrees to cough up probe docs to Abbott
Alere (NYSE:ALR) shares rose yesterday after it agreed to give documents to Abbott (NYSE:ABT), which is hoping to rescind its $6 billion offer to acquire the diagnostics company, covering probes into...
View ArticleClik here to view.
Smith & Nephew recalls Modular SMF, Modular Redapt hip implants
Smith & Nephew (NYSE:SNN) this week recalled its Modular SMF and Modular Redapt hip implants “due to a higher than anticipated complaint and adverse event trend” with the modular necks used in the...
View ArticleClik here to view.
DBV, BioNet-Asia study needle-free pertussis booster vaccination
DBV Technologies (NSDQ:DBVT) and BioNet-Asia said today that the independent Data & Safety Monitoring Board positively reviewed DBV’s needle-free vaccine patch technology, Viaskin, and that...
View ArticleClik here to view.
Adherium touts Smartinhaler asthma study
Adherium (ASK:ADR) touted data from an independent study of its Smartinhaler respiratory disease management tool in children with poorly controlled asthma. The STAAR study was conducted at Sheffield...
View ArticleClik here to view.
FDA joins pact for cybersecurity in medical devices
The FDA’s Center for Devices and Radiological Health inked a pact with the National Health Information Sharing and Analysis Center and the Medical Device Innovation, Safety and Security Consortium,...
View ArticleClik here to view.
New drug capsule delivers medicine for weeks after swallowing
Researchers from Massachusetts Institute of Technology, spurred by a challenge from Bill Gates, developed a star-shaped drug capsule that can gradually release medication and stay in the stomach for to...
View ArticleClik here to view.
Delivra president & CFO resigns, names new finance VP | Personnel Moves, Nov....
Delivra Corp. (CVE:DVA) said today that its president and CFO, Chris Schnarr, is resigning effective tomorrow and Pascal Attard has been promoted from controller to VP of finance. Attard has worked as...
View ArticleClik here to view.
Report: Apple looks at iPhone for monitoring Parkinson’s patients
Apple (NSDQ:AAPL) is reportedly conducting internal research into whether the iPhone and Apple Watch could be used to monitor drug dosage and wellness data for patients suffering from Parkinson’s...
View ArticleClik here to view.
Medtronic spinout Inspire Medical closes $38m Series F
Inspire Medical Systems, which spun out from Medtronic (NYSE:MDT) in 2007, said yesterday it closed a $37.5 million Series F financing round, as well as announcing the appointment of Marilyn Nelson to...
View ArticleClik here to view.
Titan Spine names Bird as CCO, expands sales team | Personnel Moves, Nov. 17,...
Titan Spine names Bird as CCO, expands sales team Titan Spine said it named orthopedics veteran Ted Bird to be its chief commercial officer. Bird’s resume includes executive stints at Orthofix...
View ArticleClik here to view.
Medicare issues leadless pacer coverage proposal
The Centers for Medicare and Medicaid Services said this week it is changing its coverage to now cover leadless pacemakers, but only for FDA approved studies. The change comes with a newly released...
View ArticleClik here to view.
HeartFlow wins Japanese approval for FFRct tech
HeartFlow said today it won approval from the Japanese Ministry of Health, Labour and Welfare for its HeartFlow FFRct technology, which uses algorithms to generate 3D models of blood flows and can help...
View ArticleClik here to view.
Smokers have higher lifetime risk of abdominal aortic aneurysm
(Reuters) – Smokers could be doubling their risk for a type of aneurysm that is usually fatal if it ruptures, researchers say. An abdominal aortic aneurysm (AAA) occurs when the aorta, the main vessel...
View ArticleClik here to view.
MassDevice.com +5 | The top 5 medtech stories for November 17, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View ArticleClik here to view.
Novocure touts Phase II data for tumor-treating fields in mesothelioma
NovoCure (NSDQ:NVCR) today released results from the ongoing phase 2 pilot clinical trial of its Optune device combined with chemotherapy for patients with unresectable, previously untreated...
View Article
